BG Medicine Partners with Kindstar to Offer Galectin-3 Testing in China
October 24, 2012
BG Medicine Partners with Kindstar to Offer Galectin-3 Testing in China
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- BG Medicine's Q1 Revenues Fall on Lower Service Revenue
May 15, 2012 / GenomeWeb Daily News - Amarantus Licenses Power3 Test for Parkinson's Disease
January 23, 2012 / GenomeWeb Daily News - HDL to Offer BG's Heart Failure Test as Service
March 24, 2011 / GenomeWeb Daily News - Studies Shore up BG Medicine's Push for Galectin-3 Test in Hospital Readmission Risk Assessment
March 8, 2013 / ProteoMonitor - Carmenta Acquires Option to License Stanford Technology for Preeclampsia Test
January 25, 2013 / GenomeWeb Daily News